|
Drug Information Association
38th Annual Meeting
Chicago, Illinois
June 16-20, 2002
- Barcoding Human Drugs and Biologics: A
regulatory initiative, Mary Gross (Posted 7/15/2002)
- Clinical
Data Quality: A regulator's perspective,
Stephen E. Wilson
- Communicating Risks and Benefits Through
Labeling and Leaflets, Karen Lechter (Posted 7/15/2002)
- Electronic Submissions: FDA's
Perspective, Roger Goetsch (Posted 7/15/2002)
- Electronic
Submissions: A medical reviewer's perspective,
Armando Oliva
- DailyMed
Initiative: Joint NLM/VAH/FDA project
Enhancing Patient Safety Through Accessible Medication Information,
Randy Levin
-
Implementation of the Common Technical
Document, Justina A. Molzon
- Integrated Analyses and the
CTD Sections Addressing Safety, Robert J. Temple
- Life
Cycle Management: Reviewer perspective, Jon
Clark
- Medication Guides: FDA requirements,
Karen Lechter (Posted 7/15/2002)
- Risk Management Tools, Marty
Himmel (Posted 7/15/2002)
- The
Importance of Standards: FDA initiatives, Randy Levin
- The "New" Office of
Drug Safety, Marty Himmel (Posted 7/15/2002)
Back to Top
Back to Presentations
FDA/Center for Drug Evaluation and Research
Last Updated: July 23, 2002
Originator: OTCOM/DLIS
HTML by SJW |